Lundbeck A/S, H

About Lundbeck A/S, H

Lundbeck A/S, H is a global pharmaceutical company dedicated to improving the quality of life for people suffering from brain diseases. With a strong focus on research and development, Lundbeck aims to discover and develop innovative treatments for conditions such as depression, schizophrenia, and Alzheimer’s disease.

The company operates in more than 50 countries and has a significant presence in Europe, North America, and Asia. Lundbeck’s commitment to neuroscience is reflected in its extensive pipeline of new therapies, which are designed to address unmet medical needs in the field of mental health.

At Lundbeck, collaboration is key. The company partners with academic institutions, healthcare professionals, and other organizations to advance scientific knowledge and improve patient outcomes. This collaborative approach enables Lundbeck to stay at the forefront of innovation in the pharmaceutical industry.

In addition to its research efforts, Lundbeck is also committed to corporate social responsibility. The company actively engages in initiatives that promote mental health awareness and support communities affected by brain disorders.

With a mission to make a difference in the lives of patients, Lundbeck continues to invest in cutting-edge research and development, striving to bring new hope to those living with challenging neurological and psychiatric conditions.

• Founded: 1915
• Headquarters: Copenhagen, Denmark
• Core Areas: Neuroscience, Mental Health
• Global Reach: Operations in over 50 countries